Polynucleotides for the detection of Escherichia coli O157:H7 and Escherichia coli O157:NM verotoxin producers

• US 8,088,572 B2
• Filed: 05/20/2005
• Issued: 01/03/2012
• Est. Priority Date: 05/20/2004
• Status: Expired due to Fees

• Current Assignee: AES Chemunex SA (Compagnie Merieux Alliance SAS)
• Original Assignee: AES Chemunex SA (Compagnie Merieux Alliance SAS)
• Inventors: Taylor, Gregory, Cote, Yvan, Hébert, Alexandre
• Primary Examiner(s): Kim, Young J
• Application Number:
  US11/597,163
• Publication Number:
  US 20090170076A1
• Time in Patent Office: 2,419 Days
• Field of Search: None
• US Class Current: 435/6
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C07K 14/245 Escherichia (G)
• CPC Class Codes: C12Q 1/689 for bacteria

Abstract

Polynucleotide primers and probes for the specific detection of E. coli 0157:H7 and/or E. coli 0157:NM which produces verotoxin in samples are provided. The primers and probes can be used in real time diagnostic assays for rapid detection of E. coli 0157:H7 and/or E. coli 0157:NM which produces verotoxin. The primers and probes can be used in real-time diagnostic assays for rapid detection of E. coli 0157:H7 and/or E. coli 0157:NM which produces verotoxin in a variety of situations and are capable of distinguishing E. coli 0157:H7 and/or E. coli 0157:NM which produces verotoxin from other E. coli strains. Kits comprising the primers and probes are also provided.

Claims

1. An isolated polynucleotide of 50 nucleotides or less in length comprising the sequence as set forth in SEQ ID NO:

20 or the complement thereof for use in combination with a pair of primers capable of specifically amplifying a sequence as set forth in SEQ ID NO;

19 to detect E. coli O157;

H7 and/or E. coli O157;

NM which produces verotoxin.

2. The isolated polynucleotide according to claim 1, wherein the polynucleotide is 40 nucleotides or less in length.

3. The isolated polynucleotide according to claim 1, for use as a probe.

4. The isolated polynucleotide according to claim 3, wherein said probe is a molecular beacon probe.

5. The isolated polynucleotide according to claim 4, wherein said molecular beacon probe further comprises a fluorophore, a quencher, or a combination thereof.

6. The isolated polynucleotide according to claim 4, wherein the polynucleotide consists of the sequence as set forth in SEQ ID NO:

23 or 25.

7. The isolated polynucleotide according to claim 1, wherein the polynucleotide comprises the sequence as set forth in SEQ ID NO:

23 or 25.

8. The isolated polynucleotide according to claim 1, wherein the pair of primers comprises a first polynucleotide primer comprising at least 7 consecutive nucleotides of the sequence as set forth in SEQ ID NO:

19 and a second polynucleotide primer comprising at least 7 consecutive nucleotides of a sequence complementary to SEQ ID NO;

19.

9. The isolated polynucleotide according to claim 1, wherein the pair of primers comprises a first polynucleotide primer comprising the sequence as set forth in SEQ ID NO:

21 or 27 and a second polynucleotide primer comprising a sequence complementary to SEQ ID NO;

22 or 28.

10. The isolated polynucleotide according to claim 1, wherein the pair of primers comprises a first polynucleotide primer comprising the sequence as set forth in SEQ ID NO:

21 and a second polynucleotide primer comprising a sequence complementary to SEQ ID NO;

22.

11. A combination of polynucleotides for amplification and detection of nucleic acid sequences from E. coli O157:

H7 and/or E. coli O157;

NM which produces verotoxin, said combination comprising;

the isolated polynucleotide according to claim 1;

a first polynucleotide primer comprising at least 7 consecutive nucleotides of the sequence as set forth in any one of SEQ ID NOs;

2-11;

a second polynucleotide primer comprising at least 7 consecutive nucleotides of a sequence complementary to the sequence as set forth in any one of SEQ ID NOs;

2-11;

wherein said first and second polynucleotide primers are capable of amplifying a portion of the gnd gene to which said isolated polynucleotide binds.

12. The combination of polynucleotides according to claim 11, wherein the first polynucleotide primer comprises at least 7 consecutive nucleotides of the sequence as set forth in SEQ ID NO:

43 and the second polynucleotide primer comprises at least 7 consecutive nucleotides of a sequence complementary to SEQ ID NO;

43.

13. The combination of polynucleotides according to claim 11, wherein the first polynucleotide primer comprises at least 7 consecutive nucleotides of the sequence as set forth in SEQ ID NO:

19 and the second polynucleotide primer comprises at least 7 consecutive nucleotides of a sequence complementary to SEQ ID NO;

19.

14. The combination of polynucleotides according to claim 11, wherein the first polynucleotide primer comprises a sequence as set forth in SEQ ID NO:

21 or 27 and the second polynucleotide primer comprises a sequence as set forth in SEQ ID NO;

22 or 28.

15. The combination of polynucleotides according to claim 11, wherein the first polynucleotide primer comprises a sequence as set forth in SEQ ID NO:

21 and the second polynucleotide primer comprises a sequence as set forth in SEQ ID NO;

22.

16. The combination of polynucleotides according to claim 11, wherein said isolated polynucleotide is a molecular beacon probe.

17. The combination of polynucleotides according to claim 16, wherein the isolated polynucleotide is 40 nucleotides or less in length.

18. The combination of polynucleotides according to claim 11, wherein said isolated polynucleotide further comprises a fluorophore, a quencher, or a combination thereof.

19. The combination of polynucleotides according to claim 1, wherein the isolated polynucleotide is 40 nucleotides or less in length.

20. The combination of polynucleotides according to claim 1 or 19, wherein the isolated polynucleotide comprises the sequence as set forth in SEQ ID NO:

20 or the complement thereof.

21. The combination of polynucleotides according to claim 1, wherein the isolated polynucleotide comprises the sequence as set forth in SEQ ID NO:

23 or 25.

22. The combination of polynucleotides according to claim 1, wherein the isolated polynucleotide consists of the sequence as set forth in SEQ ID NO:

23 or 25.

23. A method of detecting E. coli O157:

H7 and/or E. coli O157;

NM which produces verotoxin in a sample, said method comprising the steps of;

(i) contacting a sample suspected of containing, or known to contain, E. coli O157;

H7 and/or E. coli O157;

NM which produces verotoxin with a combination of polynucleotide primers capable of amplifying a E. coli target sequence within the gnd gene, under conditions that permit amplification of the target nucleotide sequence, said polynucleotide primers comprising;

(a) a first polynucleotide primer comprising at least 7 consecutive nucleotides of the sequence as set forth in any one of SEQ ID NOs;

2-11;

(b) a second polynucleotide primer comprising at least 7 consecutive nucleotides of a sequence complementary to any one of SEQ ID NOs;

2-11; and

(ii) detecting amplified target nucleotide sequence by contacting said amplified target nucleotide sequence with the isolated polynucleotide of claim 1,

wherein said first and second primers are capable of amplifying a portion of the gnd gene to which said isolated polynucleotide binds, and wherein detection of amplified target nucleotide sequence indicates the presence of E. coli O157;

H7 and/or E. coli O157;

NM which produces verotoxin in the sample.

24. The method according to claim 23, wherein the first polynucleotide primer comprises at least 7 consecutive nucleotides of the sequence as set forth in SEQ ID NO:

43 and the second polynucleotide primer comprises at least 7 consecutive nucleotides of a sequence complementary to SEQ ID NO;

43.

25. The method according to claim 23, wherein the first polynucleotide primer comprises at least 7 consecutive nucleotides of the sequence as set forth in SEQ ID NO:

19 and the second polynucleotide primer comprises at least 7 consecutive nucleotides of a sequence complementary to SEQ ID NO;

19.

26. The method according to claim 23, wherein the first polynucleotide primer comprises the sequence as set forth in SEQ ID NO:

21 or 27 and the second polynucleotide primer comprises a sequence complementary to SEQ ID NO;

22 or 28.

27. The method according to claim 23, wherein the first polynucleotide primer comprises the sequence as set forth in SEQ ID NO:

21 and the second polynucleotide primer comprises a sequence complementary to SEQ ID NO;

22.

28. The method according to claim 23, wherein said isolated polynucleotide is a molecular beacon probe.

29. The method according to claim 23, wherein said isolated polynucleotide further comprises a fluorophore, a quencher, or a combination thereof.

30. The method according to claim 23, wherein steps (i) and (ii) are conducted simultaneously.

31. The method according to claim 23, further comprising a step to enrich the microbial content of the sample prior to step (i).

32. The method according to claim 23, wherein the isolated polynucleotide is 40 nucleotides or less in length.

33. The method according to claim 23, wherein the isolated polynucleotide comprises the sequence as set forth in SEQ ID NO:

23 or 25.

34. The method according to claim 23, wherein the isolated polynucleotide consists of the sequence as set forth in SEQ ID NO:

23 or 25.

35. A kit for the detection of E. coli O157:

H7 and/or verotoxin producing E. coli O157;

NM in a sample, said kit comprising;

the isolated polynucleotide of claim 1;

a first polynucleotide primer comprising at least 7 consecutive nucleotides of the sequence as set forth in any one of SEQ ID NOs;

2-11;

a second polynucleotide primer comprising at least 7 consecutive nucleotides of a sequence complementary to any one of SEQ ID NOs;

2-11.

36. The kit according to claim 35, wherein the first polynucleotide primer comprises at least 7 consecutive nucleotides of the sequence as set forth in SEQ ID NO:

43 and the second polynucleotide primer comprises at least 7 consecutive nucleotides of a sequence complementary to SEQ ID NO;

43.

37. The kit according to claim 35, wherein the first polynucleotide primer comprises at least 7 consecutive nucleotides of the sequence as set forth in SEQ ID NO:

19 and the second polynucleotide primer comprises at least 7 consecutive nucleotides of a sequence complementary to SEQ ID NO;

19.

38. The kit according to claim 35, wherein said first polynucleotide primer comprises a sequence as set forth in SEQ ID NO:

21 or 27 and the second polynucleotide primer comprises a sequence as set forth in SEQ ID NO;

22 or 28.

39. The kit according to claim 35, wherein the first polynucleotide primer comprises a sequence as set forth in SEQ ID NO:

21 and the second polynucleotide primer comprises a sequence as set forth in SEQ ID NO;

22.

40. The kit according to claim 35, wherein said isolated polynucleotide is a molecular beacon probe.

41. The kit according to claim 40, wherein the isolated polynucleotide is 40 nucleotides or less in length.

42. The kit according to claim 35, wherein said isolated polynucleotide further comprises a fluorophore, a quencher, or a combination thereof.

43. The kit according to claim 35, further comprising one or more amplification reagents selected from the group of:

buffers, salts, enzymes, enzyme co-factors and nucleotides.

44. The kit according to claim 35, wherein the isolated polynucleotide is 40 nucleotides or less in length.

45. The kit according to claim 35, wherein the isolated polynucleotide comprises the sequence as set forth in SEQ ID NO:

20 or the complement thereof.

46. The kit according to claim 35, wherein the isolated polynucleotide comprises the sequence as set forth in SEQ ID NO:

23 or 25.

47. The kit according to claim 35, wherein the isolated polynucleotide consists of the sequence as set forth in SEQ ID NO:

23 or 25.